Pharmaceutical VIP: prospects and problems

Curr Med Chem. 1999 Nov;6(11):1019-34.

Abstract

Recently, multiple receptors for vasoactive intestinal peptide (VIP) have been molecularly cloned and our understanding of VIP chemistry and mechanisms of action has been broadened. The following review outlines the physiological effects of the hormone from growth regulation, reproduction, bronchodilation, vasodilation and immune interactions to neurotrophism. VIP-based drug design and non-invasive innovative delivery modes are discussed with emphasis on tumor diagnosis and treatment, impotence treatment and neuroprotection.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Humans
  • Molecular Sequence Data
  • Receptors, Vasoactive Intestinal Peptide / drug effects*
  • Vasoactive Intestinal Peptide / pharmacology*
  • Vasoactive Intestinal Peptide / physiology
  • Vasoactive Intestinal Peptide / therapeutic use

Substances

  • Receptors, Vasoactive Intestinal Peptide
  • Vasoactive Intestinal Peptide